Berry-Kravis E - Search Results

1

New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN.

Hogarth P, Gregory A, Kruer MC, Sanford L, Wagoner W, Natowicz MR, Egel RT, Subramony SH, Goldman JG, Berry-Kravis E, Foulds NC, Hammans SR, Desguerre I, Rodriguez D, Wilson C, Diedrich A, Green S, Tran H, Reese L, Woltjer RL, Hayflick SJ. Hogarth P, et al. Neurology. 2013 Jan 15;80(3):268-75. doi: 10.1212/WNL.0b013e31827e07be. Epub 2012 Dec 26. Neurology. 2013. PMID: 23269600 Free PMC article.

2

Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.

Goldman JG, Goetz CG, Berry-Kravis E, Leurgans S, Zhou L. Goldman JG, et al. Arch Neurol. 2004 Aug;61(8):1280-4. doi: 10.1001/archneur.61.8.1280. Arch Neurol. 2004. PMID: 15313848

3

Clinical features of neurodegeneration with brain iron accumulation due to a C19orf12 gene mutation.

Goldman JG, Eichenseer SR, Berry-Kravis E, Zimnowodzki S, Gregory A, Hogarth P, Hayflick SJ. Goldman JG, et al. Mov Disord. 2013 Sep;28(10):1462-3. doi: 10.1002/mds.25410. Epub 2013 Mar 13. Mov Disord. 2013. PMID: 23494994 No abstract available.

4

FMR1 CGG repeat length predicts motor dysfunction in premutation carriers.

Leehey MA, Berry-Kravis E, Goetz CG, Zhang L, Hall DA, Li L, Rice CD, Lara R, Cogswell J, Reynolds A, Gane L, Jacquemont S, Tassone F, Grigsby J, Hagerman RJ, Hagerman PJ. Leehey MA, et al. Neurology. 2008 Apr 15;70(16 Pt 2):1397-402. doi: 10.1212/01.wnl.0000281692.98200.f5. Epub 2007 Dec 5. Neurology. 2008. PMID: 18057320 Free PMC article.

5

Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations.

Goldman JG, Marr D, Zhou L, Ouyang B, Leurgans SE, Berry-Kravis E, Goetz CG. Goldman JG, et al. Mov Disord. 2011 Aug 1;26(9):1781-2. doi: 10.1002/mds.23655. Epub 2011 Apr 19. Mov Disord. 2011. PMID: 21506165 Free PMC article. No abstract available.

6

White matter disease and cognitive impairment in FMR1 premutation carriers.

Filley CM, Brown MS, Onderko K, Ray M, Bennett RE, Berry-Kravis E, Grigsby J. Filley CM, et al. Neurology. 2015 May 26;84(21):2146-52. doi: 10.1212/WNL.0000000000001612. Epub 2015 Apr 29. Neurology. 2015. PMID: 25925982 Free PMC article.

7

Initial diagnoses given to persons with the fragile X associated tremor/ataxia syndrome (FXTAS).

Hall DA, Berry-Kravis E, Jacquemont S, Rice CD, Cogswell J, Zhang L, Hagerman RJ, Hagerman PJ, Leehey MA. Hall DA, et al. Neurology. 2005 Jul 26;65(2):299-301. doi: 10.1212/01.wnl.0000168900.86323.9c. Neurology. 2005. PMID: 16043804

8

Diffusion Tensor Imaging Abnormalities in the Uncinate Fasciculus and Inferior Longitudinal Fasciculus in Phelan-McDermid Syndrome.

Bassell J, Srivastava S, Prohl AK, Scherrer B, Kapur K, Filip-Dhima R, Berry-Kravis E, Soorya L, Thurm A, Powell CM, Bernstein JA, Buxbaum JD, Kolevzon A, Warfield SK, Sahin M; Developmental Synaptopathies Consortium. Bassell J, et al. Pediatr Neurol. 2020 May;106:24-31. doi: 10.1016/j.pediatrneurol.2020.01.006. Epub 2020 Jan 31. Pediatr Neurol. 2020. PMID: 32107139 Free PMC article.

9

Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.

Bennett DA, Wilson RS, Schneider JA, Evans DA, Aggarwal NT, Arnold SE, Cochran EJ, Berry-Kravis E, Bienias JL. Bennett DA, et al. Neurology. 2003 Jan 28;60(2):246-52. doi: 10.1212/01.wnl.0000042478.08543.f7. Neurology. 2003. PMID: 12552039

10

Autism and fragile X syndrome.

Yu TW, Berry-Kravis E. Yu TW, et al. Semin Neurol. 2014 Jul;34(3):258-65. doi: 10.1055/s-0034-1386764. Epub 2014 Sep 5. Semin Neurol. 2014. PMID: 25192504 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

348 results

Search Page